Back to Trades
Kumar Neil
Chief Executive OfficerDirectorCIK 0001742485
Total Volume
$83.1M
23 filings
Purchases
$0
0 buy txns
Sales
$66.2M
130 sell txns
Net Activity
-$66.2M
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 23
- Buy transactions
- 0
- Sell transactions
- 130
- Companies
- 2
- Active
- 2025–2026
Across 23 filings between 2025–2026, Kumar Neil, Chief Executive Officer, Director, has disclosed $83.1M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $66.2M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
23 loaded
| Aug 20 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $3.7M |
| Aug 18 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.9M |
| Jun 18 | BBOT BridgeBio Oncology Therapeutics, Inc. | Kumar Neil | Insider | Award | $244.8K |
| Jun 8 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.4M |
| May 19 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.4M |
| May 11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.4M |
| Apr 13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $6.0M |
| Mar 19 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Award | $2.9M |
| Mar 16 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.5M |
| Feb 18 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.3M |
| Feb 12 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.7M |
| Jan 12 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $6.0M |
| Dec 16 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $2.2M |
| Dec 8 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.9M |
| Nov 24 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $1.7M |
| Nov 18 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Exercise | $2.2M |
| Nov 10 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $5.0M |
| Oct 10 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $4.4M |
| Sep 8 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer, Director | Sell | $4.2M |
| Aug 22 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Insider | Sell | $1.3M |
| Aug 19 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Insider | Exercise | $1.7M |
| Aug 18 | BBOT BridgeBio Oncology Therapeutics, Inc. | Kumar Neil | Insider | Other | $0 |
| Aug 11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil | Insider | Sell | $3.7M |
23 filings